Vietnam Investment Review on MSN
CStone CS2009 ESMO 2025 Trispecific Antibody Phase I Data Disclosed
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...
China's rare earth export controls have expanded to cover more products, affecting global supply chains and critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results